Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Change in Weight on Insulin Detemir (Levemir) or Isophane (NPH) Insulin (Insulatard) in Patients With Type 2 Diabetes Mellitus.

Trial Profile

Change in Weight on Insulin Detemir (Levemir) or Isophane (NPH) Insulin (Insulatard) in Patients With Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs Insulin detemir; Insulin suspension isophane
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms EVIDENCE
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 02 Mar 2009 Planned number of patients changed from 700 to 699 as reported by ClinicalTrials.gov.
    • 23 Feb 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top